オックスフォード大学『新型コロナワクチンは接種後約80日以降は逆に重症化と死亡を促進させる』との非常に不都合な1290万人対象の調査結果を公表

 

2022年10月26日水曜日

英国　子供にとってワクチン接種による抗体レベルの上昇は百害あって一利なしとの非常に不都合な研究結果

https://tokumei10.blogspot.com/2022/10/blog-post_42.html

Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales

Steven Kerr, Stuart Bedston, Declan T Bradley, Mark Joy, Emily Lowthian, Rachel M Mulholland, Ashley Akbari, F D Richard Hobbs, Srinivasa Vittal Katikireddi, Simon de Lusignan ... Show more

Author Notes

International Journal of Epidemiology, dyac199, https://doi.org/10.1093/ije/dyac199

Published:

22 October 2022

Background

Several SARS-CoV-2 vaccines have been shown to provide protection against COVID-19 hospitalization and death. However, some evidence suggests that notable waning in effectiveness against these outcomes occurs within months of vaccination. We undertook a pooled analysis across the four nations of the UK to investigate waning in vaccine effectiveness (VE) and relative vaccine effectiveness (rVE) against severe COVID-19 outcomes.

Methods

We carried out a target trial design for first/second doses of ChAdOx1(Oxford–AstraZeneca) and BNT162b2 (Pfizer–BioNTech) with a composite outcome of COVID-19 hospitalization or death over the period 8 December 2020 to 30 June 2021. Exposure groups were matched by age, local authority area and propensity for vaccination. We pooled event counts across the four UK nations.

Results

For Doses 1 and 2 of ChAdOx1 and Dose 1 of BNT162b2, VE/rVE reached zero by approximately Days 60–80 and then went negative. By Day 70, VE/rVE was –25% (95% CI: –80 to 14) and 10% (95% CI: –32 to 39) for Doses 1 and 2 of ChAdOx1, respectively, and 42% (95% CI: 9 to 64) and 53% (95% CI: 26 to 70) for Doses 1 and 2 of BNT162b2, respectively. rVE for Dose 2 of BNT162b2 remained above zero throughout and reached 46% (95% CI: 13 to 67) after 98 days of follow-up.

Conclusions

We found strong evidence of waning in VE/rVE for Doses 1 and 2 of ChAdOx1, as well as Dose 1 of BNT162b2. This evidence may be used to inform policies on timings of additional doses of vaccine.

https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyac199/6770060

→ This evidence may be used to inform policies on timings of additional doses of vaccine.

Oxford Study Finds Negative Vaccine Effectiveness Against Covid Hospitalisation and Death

by Amanuensis

29 October 2022 7:00 AM

And so we get to our position today, where our authorities are surely breathing sighs of relief that the vaccines at least offer some protection from serious disease, if not infection and transmission.

Which is just one reason why a recent paper from Oxford, Edinburgh and Swansea universities in the International Journal of Epidemiology on the risk of serious Covid or death by vaccination status is so very important.

The paper analyses hospitalisations and deaths related to Covid in the populations of England, Wales, Scotland and Northern Ireland, comparing the impact of one or two doses of vaccine with the remaining unvaccinated population. It is quite a nice paper, and unlike most other epidemiological studies to date uses the ‘Target Trial’ study design. This data analysis method attempts to calculate what results would have been found had there been a full randomised trial undertaken at the initial vaccine rollout. Because the study was based on population-wide data there are many hundreds of thousands individuals’ data in the analysis, even after attempts to match the characteristics of the vaccinated and unvaccinated. Given that there were no large-scale studies into the safety and effectiveness of the Covid vaccines when they were first given in large numbers during 2021, this type of ‘emulation’ of such a study is possibly as good an approach as we’re going to get.

The results of the analysis are, quite frankly, astounding.

The study found that the effectiveness of the vaccines at preventing hospitalisation and death maintain a level of protection for some weeks following their administration, and then go negative at around 60-80 days post-vaccination. That means within two to three months, the vaccinated experienced a higher rate of Covid hospitalisation and death than the unvaccinated.

https://dailysceptic.org/2022/10/29/oxford-study-finds-negative-vaccine-effectiveness-against-covid-hospitalisation-and-death/

 

2022年10月19日水曜日

肝心の自然免疫破壊を対価に無駄に武漢株抗体を大量作成する狂った獲得免疫が得られるワクチン（笑）

https://tokumei10.blogspot.com/2022/10/blog-post_19.html

2022年10月29日土曜日

ワクチン接種者全員が自然免疫を事前に何の説明もなく抑制された不当かつ違法な医療行為の被害者

https://tokumei10.blogspot.com/2022/10/blog-post_38.html

、、、（爆ｗｗｗｗｗｗｗｗｗｗｗｗｗｗｗ